Jay Polychem India Profile
Key Indicators
- Authorised Capital ₹ 100.00 Cr
- Paid Up Capital ₹ 95.91 Cr
- Company Age 33 Year, 6 Months
- Last Filing with ROC 31 Mar 2015
- Open Charges ₹ 2,507.51 Cr
- Satisfied Charges ₹ 2,119.17 Cr
- Revenue Growth 2.29%
- Profit Growth -449.91%
- Ebitda -138.92%
- Net Worth -28.45%
- Total Assets 18.26%
About Jay Polychem India
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U72300DL1991PLC044884
-
Company No.
044884
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
08 Jul 1991
-
Date of AGM
30 Sep 2015
-
Date of Balance Sheet
31 Mar 2015
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Jay Polychem India?
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Madhok
|
Director | 01-May-2006 | Current |
|
Inderpal Sandhu
|
Director | 05-Sep-2013 | Current |
|
Harpreet Singh
|
Director | 01-Oct-2015 | Current |
|
Mamta
|
Director | Current | |
|
Neelima Goel
|
Director | Current |
Financial Performance of Jay Polychem India.
Jay Polychem India Limited, for the financial year ended 2015, experienced modest growth in revenue, with a 2.29% increase. The company also saw a substantial fall in profitability, with a 449.91% decrease in profit. The company's net worth observed a substantial decline by a decrease of 28.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jay Polychem India?
Unlock access to Jay Polychem India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Taxortium Consultants LlpNeelima Goel is a mutual person
-
Vanila Dermologie Private Limited
Neelima Goel is a mutual person
Charges (Loans)
₹2,507.51 Cr
₹2,119.17 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 1672.65 Cr
- Bank Of India : 392.00 Cr
- Union Bank Of India : 90.00 Cr
- United Bank Of India : 79.00 Cr
- Andhra Bank : 77.00 Cr
- Others : 196.86 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 May 2015 | Andhra Bank | ₹77.00 Cr | Open |
| 31 Mar 2015 | Corporation Bank | ₹36.75 Cr | Open |
| 31 Dec 2014 | Bank Of India | ₹196.00 Cr | Open |
| 31 Dec 2014 | Others | ₹15.00 Cr | Open |
| 31 Dec 2014 | Others | ₹1.90 Cr | Open |
How Many Employees Work at Jay Polychem India?
Unlock and access historical data on people associated with Jay Polychem India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jay Polychem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Polychem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
